- Title
- Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
- Creators
- Bhavana Pothuri - GOG Foundation and Laura & Isaac Perlmutter Cancer Center, New York University Langone Health, New York, NY, United StatesGiorgio Valabrega - University of Torino, Torino, ItalyAna Oaknin - Hebron UniversityWhitney Graybill - Medical University of South CarolinaAna Beatriz Sánchez - Hospital General Universitario de ElcheColleen McCormick - UNM Comprehensive Cancer CenterJean-François Baurain - Cliniques Universitaires Saint-LucAnna Tinker - University of British ColumbiaHannelore Denys - Ghent University HospitalRoisin O'Cearbhaill - Memorial Sloan Kettering Cancer CenterSakari Hietanen - Turku University HospitalRichard Moore - University of RochesterAnja Knudsen - Odense University HospitalThibault de La Motte Rouge - Eugene Marquis Cancer Center, Rennes, FranceFlorian Heitz - Kliniken Essen-MitteTally Levy - Tel Aviv UniversityWhitney York - GSK, Philadelphia, PA, United StatesIzabela Malinowska - GSK, Waltham, MA, United StatesBradley Monk - University of ArizonaAntonio González-Martín - Universidad de Navarra
- Publication Details
- Gynecologic oncology, Vol.190, pp.S295-S296
- Publisher
- Elsevier Inc
- Identifiers
- 991006118332202656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article
Journal article
Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic oncology, Vol.190, pp.S295-S296
11/2024
Metrics
1 Record Views